Tuesday, September 28, 2021
wellness India Expo
Home Tags SARS CoV2

Tag: SARS CoV2

Phase-3 trial results show COVAXIN is 77.8% effective against symptomatic COVID-19

Efficacy analysis demonstrates COVAXIN to be 93.4% effective against severe symptomatic COVID-19. Efficacy data demonstrates 65.2% protection against the SARS-CoV-2, B.1.617.2 Delta variant..................................

Biophore applies for DCGI emergency use approval of Aviptadil for COVID-19

Aviptadil has shown significant results in clinical trials against COVID-19. Biophore has developed both the API and the formulation in-house...........................

Meril gets ICMR nod for indigenous Covid-19 self-test, CoviFind

A simple, less invasive nasal swab-based home test offering quick results in 15 minutes is priced at Rs. 250 per test and will be available in pharmacies across India............................

Indian researchers unveil structure of key protein in COVID-19 virus

The IIT Mandi team has experimentally studied the structural conformations of SARS-CoV-2 NSP1 under various conditions – in an organic solvent, membrane mimetic environment, and inside liposomes...........................

COVID-19: How data can help generate public health response?

Digitizing patient data at the hospitals would not take much time with the help of technological tools like scanners and spreadsheets, writes Dr Monika Chaudhary.........................

J Mitra launches India’s first Covid-19 neutralizing antibody test

Covid-19 Neutralizing Antibody Microlisa Elisa Test is the first commercial laboratory test to detect neutralizing antibodies against SARS-CoV-2, the virus that causes Covid-19......................

IIT Madras researchers study the high transmission potential of Coronavirus

Studying the SARS-CoV-2, which causes COVID-19, using various computational tools, the team set out to understand how spike proteins of these different virus strains interact with the human cells.....................

DBT funds phase-1 trials of Gennova’s novel mRNA-based COVID-19 vaccine

Vaccine Discovery Programme supported by the Department of Biotechnology under the Mission COVID Suraksha, implemented by BIRAC, moves into clinical trials...............

COVID-19 second wave won’t be severe but shorter & might fizzle...

The experts at Neuberg’s Panel discussion on “Coronavirus – variants and vaccination” said there will be the second wave of Coronavirus however it will not be as severe as the first one and it will fizzle off sooner....................

Pfizer & BioNTech COVID-19 vaccine candidate achieves success in phase 3...

The vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis...................